Actively Recruiting

Age: 18Years +
All Genders
ID00515567

Utilization of Explanted Lungs for Isolation of Tissue Samples and Primary Cell Lines to Study Pulmonary Fibrosis

Led by University of Chicago · Updated on 2026-01-13

90

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Pulmonary Fibrosis is a condition where lung tissue becomes scarred and thickened, reducing the lungs' ability to transfer oxygen to the blood. Researchers aim to study this process at the cellular level by comparing lung tissue from patients with pulmonary fibrosis to those without the disease. This observational study is designed to increase understanding of the causes of pulmonary fibrosis using explanted lung tissues. The study involves collecting lung tissue samples from patients who are undergoing lung transplant surgery. These samples will be used to isolate cells such as fibroblasts and analyze cytokines associated with pulmonary fibrosis. There are no study drugs or treatments given, as this is an observational study focused on tissue analysis. Participants will be patients awaiting lung transplant surgery who agree to provide consent for their lung tissue to be used in research. Researchers will assess the cellular components involved in pulmonary fibrosis and measure specific markers related to the disease. The study is sponsored by the University of Chicago and aims to improve knowledge about pulmonary fibrosis through detailed tissue studies. Participation involves tissue donation and data collection related to the lung samples.

CONDITIONS

Brief Title

Explanted Lung Tissues With Pulmonary Fibrosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • All patients awaiting lung transplant
Not Eligible

You will not qualify if you...

  • Patients who will not give consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - At time of lung transplant surgery

Participants who undergo lung transplant surgery provide explanted lung tissues for the study to assess fibroblasts and cytokines associated with pulmonary fibrosis.

1 visit (in-person) at surgery

Long-term Monitoring

Duration - Up to study completion in December 2026

Participants are observed after tissue collection for any additional assessments related to pulmonary fibrosis research.

Follow-up visits as needed

Trial Site Locations

Total: 1 location

1

The University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

Loading map...

Research Team

N

Nickolai Dulin, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Randomised Clinical Trial of a Digital Self-management Pac...

Lung Diseases, Interstitial

Actively Recruiting

4 locations

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Stu...

Pulmonary Fibrosis

Actively Recruiting

152 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here